Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer Reaffirms CV Disease Commitment With Deal For Akcea's ANGPTL3 Drug
Oct 07 2019
•
By
Jessica Merrill
Pfizer is going big and broad in cardiovascular disease • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Cardiovascular
More from Therapeutic Category